Ross Louie E, Powe Barbara D, Taylor Yhenneko J, Howard Daniel L
Institute for Health, Social, and Community Research, Shaw University, Raleigh, NC 27601, USA.
Am J Mens Health. 2008 Jun;2(2):156-64. doi: 10.1177/1557988307309323. Epub 2007 Dec 5.
Prostate cancer is the second leading cancer killer in men. Men in general and African American men in particular face crucial decisions regarding prostate cancer screening and perhaps treatment for this disease. Major health organizations agree that men should discuss prostate cancer screening with their physicians or other health care professionals. The purpose of the study was to examine sociodemographic and other correlates of physician-patient discussions regarding the advantages and disadvantages of the prostate-specific antigen (PSA) test among African American men aged 40 or older. A majority of African American men reported having discussed the advantages and disadvantages of prostate cancer screening and/or testing with their physicians before ordering it, and physician-patient discussions about the PSA test were associated with increased screening in African American men. Inasmuch as African American men have greater prostate cancer incidence and mortality over other groups, future attempts should be made to find meaningful correlates of PSA screening and test use to help reduce the burden of this disease.
前列腺癌是男性第二大致命癌症。一般男性，尤其是非裔美国男性，在前列腺癌筛查以及可能的疾病治疗方面面临着关键抉择。主要的健康组织一致认为，男性应该与他们的医生或其他医疗保健专业人员讨论前列腺癌筛查事宜。该研究的目的是调查40岁及以上非裔美国男性中，医患关于前列腺特异性抗原（PSA）检测利弊讨论的社会人口学及其他相关因素。大多数非裔美国男性报告称，在进行前列腺癌筛查和/或检测之前，他们曾与医生讨论过其利弊，并且医患关于PSA检测的讨论与非裔美国男性筛查率的提高有关。鉴于非裔美国男性比其他群体有更高的前列腺癌发病率和死亡率，未来应努力找到PSA筛查及检测使用的有意义的相关因素，以帮助减轻这种疾病的负担。
